Atlas Trials

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Clinical trial NCT03654755 · TERMINATED

Trial details

NCT number
NCT03654755
Sponsor
Asana BioSciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2018-09-29
Primary completion
2019-10-29
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.